- Report
- October 2024
- 80 Pages
North Macedonia
From €2675EUR$2,884USD£2,302GBP
- Report
- October 2024
- 23 Pages
North Macedonia
From €995EUR$1,073USD£856GBP
- Report
- October 2024
- 24 Pages
Cameroon
From €995EUR$1,073USD£856GBP
- Report
- October 2024
- 21 Pages
North Macedonia
From €995EUR$1,073USD£856GBP
- Report
- October 2024
- 79 Pages
Slovenia
From €2675EUR$2,884USD£2,302GBP
- Report
- October 2024
- 27 Pages
Ukraine
From €995EUR$1,073USD£856GBP
- Report
- October 2024
- 22 Pages
Slovenia
From €995EUR$1,073USD£856GBP
- Report
- October 2024
- 24 Pages
Pakistan
From €995EUR$1,073USD£856GBP
- Report
- October 2024
- 81 Pages
Lithuania
From €2675EUR$2,884USD£2,302GBP
- Report
- October 2024
- 23 Pages
Lithuania
From €995EUR$1,073USD£856GBP
- Report
- October 2024
- 24 Pages
Slovakia
From €995EUR$1,073USD£856GBP
- Report
- October 2024
- 21 Pages
Lithuania
From €995EUR$1,073USD£856GBP
- Report
- October 2024
- 77 Pages
Guatemala
From €2675EUR$2,884USD£2,302GBP
- Report
- October 2024
- 84 Pages
Kazakhstan
From €2675EUR$2,884USD£2,302GBP
- Report
- October 2024
- 23 Pages
Estonia
From €995EUR$1,073USD£856GBP
- Report
- October 2024
- 24 Pages
Kazakhstan
From €995EUR$1,073USD£856GBP
- Report
- October 2024
- 21 Pages
Guatemala
From €995EUR$1,073USD£856GBP
- Report
- September 2024
- 29 Pages
South Korea
From €995EUR$1,073USD£856GBP
From €2675EUR$2,884USD£2,302GBP
- Report
- September 2024
- 102 Pages
Hungary
From €2675EUR$2,884USD£2,302GBP
The Ibuprofen market is a segment of the Over the Counter (OTC) Drugs industry. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain, fever, and inflammation. It is available in a variety of forms, including tablets, capsules, gels, creams, and liquids. Ibuprofen is one of the most widely used OTC drugs, and is available in both generic and branded forms. It is often used to treat mild to moderate pain, as well as inflammation associated with arthritis and other conditions. Ibuprofen is also used to reduce fever and to treat menstrual cramps.
The Ibuprofen market is highly competitive, with a number of major players. Some of the leading companies in the market include Johnson & Johnson, Bayer, Pfizer, GlaxoSmithKline, and Novartis. Show Less Read more